Riskpilot
← Back to search
Sign in
Get full access
Orifarm Generics AB
AB
Active
Org 5566228937
Klara Södra Kyrkogata 1, 111 52
Stockholm
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 2002
10-19 employees
Watchlist
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Orifarm Generics AB
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (2)
LC
Lars Christian Jakob Vallentin
Chief Executive Officer
Chief Executive Officer
2022
MC
Mats Christer Roland Persson
Chief Auditor
Chief Auditor
2022
Former (2)
LG
Lovisa Gertrud Cecilia Dahl Nelson
Authorized Recipient of Service
Authorized Recipient of Service
2022 – 2022
KH
Karsten Haumann
Chief Executive Officer
Chief Executive Officer
2022 – 2022
Board of directors
Non-executive oversight
Name
Role
Member since
Current (5)
NL
Nicki Lund Kristensen
Board of Directors
2025
TB
Thomas Brandhof
Board of Directors
2024
HB
Hans Bögh-Sörensen
Chairman
2022
MF
Mads Fink Eriksen
Board of Directors
2025
BB
Birgitte Bögh-Sörensen
Deputy Board Member
2022
Former (2)
DD
Dennis Dencher
Board of Directors
2022 – 2024
ES
Erik Sandberg
Board of Directors
2022 – 2025
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
ORIFARM GENERICS HOLDING A/S
Company
100%
100%
2025
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.